title: The treatment of iatrogenic male incontinence: latest results and future perspectives.
abstract: Male Stress Urinary Incontinence (SUI) is an increasingly recognized problem particularly after the treatment of prostate cancer. Postprostatectomy incontinence is a major problem that needs to be solved, since it has great impact on quality of life affecting the patient's physical activity and social well-being. The initial treatment for SUI that persists after 12 months consists of conservative measures such as pelvic floor muscle exercises and behavioral therapy. Properly selected and informed patients can also be treated efficiently with minimally invasive procedures such as the implantation of a male suburethral sling, although the experience with such devices is not extensive. However, the implantation of artificial urinary sphincter is the gold standard therapy.
authors.affiliation: 1st Department of Urology, Laiko University Hospital, Athens, Greece.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Adamakis
authors.forename: Ioanna
authors.initials: I
authors.lastname: Vasileiou
authors.forename: Constantinos A
authors.initials: CA
authors.lastname: Constantinides
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D001676:Biofeedback, Psychology; D000068736:Duloxetine Hydrochloride; D004599:Electric Stimulation Therapy; D004867:Equipment Design; D005081:Exercise Therapy; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D009119:Muscle Contraction; D056687:Off-Label Use; D017773:Pelvic Floor; D011468:Prostatectomy / Q000009:adverse effects; D013234:Stem Cells; D053825:Suburethral Slings; D013876:Thiophenes / Q000627:therapeutic use; D014550:Urinary Incontinence, Stress / Q000175:diagnosis / Q000628:therapy*; D016741:Urinary Sphincter, Artificial
chemical_list: D000928:Antidepressive Agents; D013876:Thiophenes; D000068736:Duloxetine Hydrochloride